Implanet announced that it has been granted intellectual protection for its JAZZ technology in Europe until 2031.
The patent applies to the entire JAZZ system and definitively secures full protection of the implant's technical characteristics.
"This announcement validates the excellent upstream work accomplished by our research and development team to put in place long-term barriers to entry, by significantly reducing any possible attempts to develop a rival product. We can now capitalize on this patent to accelerate JAZZ's transformation into a technological platform comprising a comprehensive range of implants covering 100 percent of our market. Our highly promising portfolio of innovations will enable us to rapidly meet the demands of the entire spine surgeon community," said Ludovic Lastennet, CEO of Implanet.
More articles on devices:
5 things to know about the SpineGuard "smart screw" European patent
Medtronic Spinal employees rack-up 4.8k charitable hours — 5 things to know
X-Bolt Orthopaedics receives U.S. patent for jig device in hip nailing system